9-127843163-C-T
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001114753.3(ENG):c.150G>A(p.Ser50Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,461,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001114753.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- telangiectasia, hereditary hemorrhagic, type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, ClinGen
- hereditary hemorrhagic telangiectasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- juvenile polyposis syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ENG | NM_001114753.3 | c.150G>A | p.Ser50Ser | synonymous_variant | Exon 2 of 15 | ENST00000373203.9 | NP_001108225.1 | |
| ENG | NM_000118.4 | c.150G>A | p.Ser50Ser | synonymous_variant | Exon 2 of 14 | NP_000109.1 | ||
| ENG | NM_001406715.1 | c.150G>A | p.Ser50Ser | synonymous_variant | Exon 2 of 8 | NP_001393644.1 | ||
| ENG | NM_001278138.2 | c.-397G>A | 5_prime_UTR_variant | Exon 2 of 15 | NP_001265067.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251466 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Hereditary hemorrhagic telangiectasia Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at